Home Cart 0 Sign in  
X

[ CAS No. 88912-27-0 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 88912-27-0
Chemical Structure| 88912-27-0
Chemical Structure| 88912-27-0
Structure of 88912-27-0 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 88912-27-0 ]

Related Doc. of [ 88912-27-0 ]

Alternatived Products of [ 88912-27-0 ]

Product Details of [ 88912-27-0 ]

CAS No. :88912-27-0 MDL No. :MFCD03094685
Formula : C6H4ClNO2 Boiling Point : -
Linear Structure Formula :- InChI Key :MYAZXWFEMDJTFE-UHFFFAOYSA-N
M.W : 157.55 Pubchem ID :2735816
Synonyms :

Calculated chemistry of [ 88912-27-0 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.0
Num. rotatable bonds : 1
Num. H-bond acceptors : 3.0
Num. H-bond donors : 1.0
Molar Refractivity : 36.21
TPSA : 50.19 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.54 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.94
Log Po/w (XLOGP3) : 1.01
Log Po/w (WLOGP) : 1.43
Log Po/w (MLOGP) : -0.51
Log Po/w (SILICOS-IT) : 1.39
Consensus Log Po/w : 0.85

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.56

Water Solubility

Log S (ESOL) : -1.83
Solubility : 2.32 mg/ml ; 0.0148 mol/l
Class : Very soluble
Log S (Ali) : -1.65
Solubility : 3.5 mg/ml ; 0.0222 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.0
Solubility : 1.57 mg/ml ; 0.00998 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.24

Safety of [ 88912-27-0 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 88912-27-0 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 88912-27-0 ]
  • Downstream synthetic route of [ 88912-27-0 ]

[ 88912-27-0 ] Synthesis Path-Upstream   1~15

  • 1
  • [ 88912-27-0 ]
  • [ 74-88-4 ]
  • [ 98273-79-1 ]
YieldReaction ConditionsOperation in experiment
56%
Stage #1: With potassium carbonate In dimethyl sulfoxide for 0.5 h;
Stage #2: at 20℃; for 2 h;
Potassium carbonate (36.3 g, 263 mmol) was added to 3-chloroisonicotinic acid (10.35 g, 65.7 mmol) in DMSO (50 mL). After 30 min, MeI (8.22 mL, 131 mmol) was added. The mixture was stirred at room temperature for 2 h, quenched with saturated NH4Cl (300 mL) and water (200 mL), and extracted with EtOAc (3x200 mL). The combined extracts were washed with brine (2x50 mL), dried (MgSO4) and concentrated. Silica gel chromatography, eluting with 10-30percent ethyl acetate in hexanes, gave methyl 3-chloroisonicotinate as a colorless liquid (6.275 g, 56percent yield). MS (ES+) m/z: 172 (M+H); LC retention time: 2.45 min (analytical
Reference: [1] Patent: WO2009/100171, 2009, A1, . Location in patent: Page/Page column 70
[2] Synthetic Communications, 1997, vol. 27, # 6, p. 1075 - 1086
  • 2
  • [ 67-56-1 ]
  • [ 88912-27-0 ]
  • [ 98273-79-1 ]
Reference: [1] European Journal of Organic Chemistry, 2014, vol. 2014, # 10, p. 2140 - 2149
[2] Journal of the American Chemical Society, 2018, vol. 140, # 9, p. 3322 - 3330
  • 3
  • [ 186581-53-3 ]
  • [ 88912-27-0 ]
  • [ 98273-79-1 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1997, vol. 34, # 1, p. 27 - 32
  • 4
  • [ 55-22-1 ]
  • [ 13958-93-5 ]
  • [ 88912-27-0 ]
Reference: [1] Chemische Berichte, 1928, vol. 61, p. 2214
  • 5
  • [ 55-22-1 ]
  • [ 7719-09-7 ]
  • [ 13958-93-5 ]
  • [ 88912-27-0 ]
Reference: [1] Chemische Berichte, 1928, vol. 61, p. 2214
  • 6
  • [ 88912-27-0 ]
  • [ 10128-71-9 ]
Reference: [1] Chemische Berichte, 1928, vol. 61, p. 2214
  • 7
  • [ 626-60-8 ]
  • [ 88912-27-0 ]
YieldReaction ConditionsOperation in experiment
12% With hydrogenchloride; n-butyllithium; carbon dioxide; diisopropylamine; lithium diisopropyl amide In tetrahydrofuran A.
3-Chloro-N-(4-chlorophenyl)pyridine-4-carboxamide.
A solution of 3-chloropyridine (1.00 mL, 10.5 mmol) in THF at -78° C. was treated dropwise with a solution of lithium diisopropylamide in THF [freshly prepared by addition of butyllithium (7.21 mL, 11.5 mmol) to diisopropylamine (11.5 mmol)].
After 0.25 h, the mixture was treated with carbon dioxide(g) and slowly warmed to ambient temperature.
The mixture was concentrated, partitioned between EtOAc and water, and the aqueous layer was washed with EtOAc (2*).
The pH of the aqueous layer was adjusted (~3) by addition of 1 N HCl and then washed with EtOAc (3*).
The combined extracts were dried with magnesium sulfate and concentrated.
The residue was recrystallized from EtOAc yielding 200 mg (12percent) of 3-chloroisonicotinic acid.
Reference: [1] Patent: US6610704, 2003, B1,
  • 8
  • [ 55-22-1 ]
  • [ 88912-27-0 ]
Reference: [1] Tetrahedron, 2002, vol. 58, # 33, p. 6723 - 6728
  • 9
  • [ 55-22-1 ]
  • [ 13958-93-5 ]
  • [ 88912-27-0 ]
Reference: [1] Chemische Berichte, 1928, vol. 61, p. 2214
  • 10
  • [ 626-60-8 ]
  • [ 124-38-9 ]
  • [ 88912-27-0 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1997, vol. 34, # 1, p. 27 - 32
[2] Bioorganic and Medicinal Chemistry Letters, 2013, vol. 23, # 6, p. 1846 - 1852
  • 11
  • [ 188677-48-7 ]
  • [ 88912-27-0 ]
Reference: [1] Synthetic Communications, 1997, vol. 27, # 6, p. 1075 - 1086
  • 12
  • [ 3034-31-9 ]
  • [ 88912-27-0 ]
Reference: [1] Synthetic Communications, 1997, vol. 27, # 6, p. 1075 - 1086
  • 13
  • [ 55-22-1 ]
  • [ 7719-09-7 ]
  • [ 13958-93-5 ]
  • [ 88912-27-0 ]
Reference: [1] Chemische Berichte, 1928, vol. 61, p. 2214
  • 14
  • [ 88912-27-0 ]
  • [ 211678-96-5 ]
Reference: [1] Patent: US2014/163035, 2014, A1, . Location in patent: Page/Page column
  • 15
  • [ 64-17-5 ]
  • [ 88912-27-0 ]
  • [ 211678-96-5 ]
Reference: [1] Patent: WO2013/14587, 2013, A1, . Location in patent: Page/Page column 69
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 88912-27-0 ]

Chlorides

Chemical Structure| 1060810-03-8

[ 1060810-03-8 ]

5-Chloro-2-methylisonicotinic acid

Similarity: 0.90

Chemical Structure| 88912-26-9

[ 88912-26-9 ]

2,5-Dichloroisonicotinic acid

Similarity: 0.90

Chemical Structure| 13958-93-5

[ 13958-93-5 ]

3,5-Dichloroisonicotinic acid

Similarity: 0.86

Chemical Structure| 530156-90-2

[ 530156-90-2 ]

2-Bromo-5-chloroisonicotinic acid

Similarity: 0.85

Chemical Structure| 623585-74-0

[ 623585-74-0 ]

Methyl 2,5-dichloroisonicotinate

Similarity: 0.83

Carboxylic Acids

Chemical Structure| 1060810-03-8

[ 1060810-03-8 ]

5-Chloro-2-methylisonicotinic acid

Similarity: 0.90

Chemical Structure| 88912-26-9

[ 88912-26-9 ]

2,5-Dichloroisonicotinic acid

Similarity: 0.90

Chemical Structure| 13958-93-5

[ 13958-93-5 ]

3,5-Dichloroisonicotinic acid

Similarity: 0.86

Chemical Structure| 530156-90-2

[ 530156-90-2 ]

2-Bromo-5-chloroisonicotinic acid

Similarity: 0.85

Chemical Structure| 59782-85-3

[ 59782-85-3 ]

2,5-Dichloronicotinic acid

Similarity: 0.80

Related Parent Nucleus of
[ 88912-27-0 ]

Pyridines

Chemical Structure| 1060810-03-8

[ 1060810-03-8 ]

5-Chloro-2-methylisonicotinic acid

Similarity: 0.90

Chemical Structure| 88912-26-9

[ 88912-26-9 ]

2,5-Dichloroisonicotinic acid

Similarity: 0.90

Chemical Structure| 13958-93-5

[ 13958-93-5 ]

3,5-Dichloroisonicotinic acid

Similarity: 0.86

Chemical Structure| 530156-90-2

[ 530156-90-2 ]

2-Bromo-5-chloroisonicotinic acid

Similarity: 0.85

Chemical Structure| 623585-74-0

[ 623585-74-0 ]

Methyl 2,5-dichloroisonicotinate

Similarity: 0.83